Inventor · disambiguated record
Megan Foley
Also filed as: FOLEY MEGAN · FOLEY MEGAN ALENE · FOLEY MEGAN ALENE CLOONAN
16 granted patents·14 pending applications·26 citations·filing 2010–2023
89Inventor score
Top patents by PatentIndex Score
30 records- 0191US9850262B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2016·Granted Dec 26, 2017·6 cites·25 claims
- 0290US11242361B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2020·Granted Feb 8, 2022·2 cites·34 claims
- 0384US11746098B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2020·Granted Sep 5, 2023·1 cites·25 claims
- 0481US10266526B2Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancerEPIZYME INC·Filed 2015·Granted Apr 23, 2019·3 cites·17 claims
- 0581US9556166B2Proteostasis regulatorsFOLEY MEGAN·Filed 2012·Granted Jan 31, 2017·8 cites·5 claims
- 0679US10179773B2Isoxazole carboxamides as irreversible SMYD inhibitorsEPIZYME INC·Filed 2015·Granted Jan 15, 2019·2 cites·20 claims
- 0778US10577363B2Substituted piperidine compoundsEPIZYME INC·Filed 2015·Granted Mar 3, 2020·2 cites·19 claims
- 0876US12116358B2Substituted indoles and methods of use thereofEPIZYME INC·Filed 2019·Granted Oct 15, 2024·1 cites·70 claims
- 0976US11958873B2Proteasome activity enhancing compoundsKINETA INC·Filed 2021·Granted Apr 16, 2024·0 cites·35 claims
- 1074US2023101819A1SMYD InhibitorsEPIZYME INC·Filed 2021·Application pending·0 cites
- 1171US2024116894A1Proteasome activity enhancing compoundsKINETA INC·Filed 2023·Application pending·0 cites
- 1268US12180189B2Proteostasis regulatorsKINETA INC·Filed 2019·Granted Dec 31, 2024·0 cites·10 claims
- 1367US2021198252A1Smyd inhibitorsEPIZYME INC·Filed 2020·Application pending·0 cites
- 1464US8779198B2Ring opening of lactones and lactamsFOLEY MEGAN ALENE·Filed 2010·Granted Jul 15, 2014·1 cites·9 claims
- 1564US2018282352A1Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1661US2020102314A1Substituted pyrrolidine compoundsEPIZYME INC·Filed 2019·Application pending·0 cites
- 1761US2021198277A1Amine-substituted aryl or heteroaryl compoundsEPIZYME INC·Filed 2020·Application pending·0 cites
- 1861US2019322660A1Smyd inhibitorsEPIZYME INC·Filed 2019·Application pending·0 cites
- 1960US2020048195A1Substituted pyrrolidine carboxamide compoundsEPIZYME INC·Filed 2019·Application pending·0 cites
- 2055US10669243B2Isoxazole carboxamides as irreversible SMYD inhibitorsEPIZYME INC·Filed 2019·Granted Jun 2, 2020·0 cites·19 claims
- 2155US10532996B2Proteostasis regulatorsPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Granted Jan 14, 2020·0 cites·5 claims
- 2253US2020148650A1Isoxazole carboxamide compoundsEPIZYME INC·Filed 2019·Application pending·0 cites
- 2350US2017253601A1Substituted Pyrrolidine CompoundsEPIZYME INC·Filed 2015·Application pending·0 cites
- 2450US2017247326A1Substituted Pyrrolidine Carboxamide CompoundsEPIZYME INC·Filed 2015·Application pending·0 cites
- 2547US2017355712A1Amine-substituted aryl or heteroaryl compoundsEPIZYME INC·Filed 2017·Application pending·0 cites
- 2645US9399647B2Proteasome activity modulating compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2014·Granted Jul 26, 2016·0 cites·11 claims
- 2745US2020123142A1Substituted Cyclohexylamine CompoundsEPIZYME INC·Filed 2018·Application pending·0 cites
- 2844US10428029B2Isoxazole carboxamide compoundsEPIZYME INC·Filed 2015·Granted Oct 1, 2019·0 cites·10 claims
- 2944US2015166567A1Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3036US10106510B2Substituted isoxazoles for treating cancerEPIZYME INC·Filed 2015·Granted Oct 23, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Megan Foley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →